Tong Ren Tang
Tong Ren Tang specalized in traditional Chinese medicine and therapy.
Tong Ren Tang, founded in 1669 and headquartered in Beijing, is a leading Chinese pharmaceutical company. As a subsidiary of Beijing TRT Group, the company was listed on the Shanghai Stock Exchange in 1997. Rivals with direct and indirect competition include Pientzehuang Pharmaceutical, Yunan Baiyao, and Dong-E-E-Jiao.
Intracardiac Echocardiography Enterprise, Cardioacc, Wins Angel Round Financing
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
East China medicine "liraglutide" goes to sea
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Chinese medicine stocks recovered significantly in the afternoon
Pharmaceutical and biological stocks continued to strengthen in the afternoon
State Food and Drug Administration: Yitong Biotechnology (Guangzhou) Co., Ltd. stopped production for rectification